Shelton Capital Management’s Integra LifeSciences IART Stock Holding History

Shelton Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,687	Closed	-$212K	–	741
2023 Q1	$212K	Hold	3,687	–	–	0.01%	668
2022 Q4	$207K	Buy	+3,687	New	+$188K	0.02%	634
2022 Q3	–	Sell	-3,953	Closed	-$214K	–	704
2022 Q2	$214K	Hold	3,953	–	–	0.01%	642
2022 Q1	$254K	Hold	3,953	–	–	0.01%	651
2021 Q4	$265K	Hold	3,953	–	–	0.01%	628
2021 Q3	$271K	Hold	3,953	–	–	0.01%	605
2021 Q2	$270K	Hold	3,953	–	–	0.01%	633
2021 Q1	$273K	Hold	3,953	–	–	0.01%	599
2020 Q4	$257K	Sell	3,953 -341	-8%	-$18.4K	0.01%	565
2020 Q3	$203K	Hold	4,294	–	–	0.01%	690
2020 Q2	$202K	Sell	4,294 -233	-5%	-$11.5K	0.01%	594
2020 Q1	$202K	Sell	4,527 -200	-4%	-$10.5K	0.01%	540
2019 Q4	$275K	Hold	4,727	–	–	0.02%	573
2019 Q3	$284K	Sell	4,727 -325	-6%	-$19.4K	0.02%	549
2019 Q2	$282K	Buy	5,052 +4,771	+1,698%	+$246K	0.02%	578
2019 Q1	$5.05K	Sell	281 -4,771	-94%	-$243K	0.02%	575
2018 Q4	$228K	Hold	5,052	–	–	0.02%	628
2018 Q3	$333K	Buy	+5,052	New	+$314K	0.02%	539
2018 Q2	–	Sell	-6,182	Closed	-$342K	–	870
2018 Q1	$342K	Buy	6,182 +751	+14%	+$39.4K	0.02%	498
2017 Q4	$260K	Hold	5,431	–	–	0.02%	664
2017 Q3	$274K	Sell	5,431 -507	-9%	-$26K	0.02%	609
2017 Q2	$324K	Buy	5,938 +371	+7%	+$17.7K	0.02%	530
2017 Q1	$235K	Buy	5,567 +727	+15%	+$31.1K	0.02%	717
2016 Q4	$208K	Buy	+4,840	New	+$197K	0.02%	815

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shelton Capital Management's IART Position: Q2 2023 in Review

Shelton Capital Management sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 3,687 shares — an estimated $212K sold.

Shelton Capital Management first reported a position in IART in Q4 2016 and held it in 24 quarters. The position peaked at $342K in Q1 2018. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

Shelton Capital Management reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
Shelton Capital Management sold 3,687 Integra LifeSciences shares in Q2 2023, an estimated $212K.
Shelton Capital Management first reported a position in Integra LifeSciences in Q4 2016 and held it in 24 quarters.
Shelton Capital Management's Integra LifeSciences position peaked at $342K in Q1 2018.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Shelton Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.